Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir oral solution versus tablet pharmacokinetic comparison in healthy Thai volunteers
TCTR20210903002Phase 1Enrolling by invitation
- Sponsor
- Chulabhorn Royal Academy
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of favipiravir (2 arms), sponsored by Chulabhorn Royal Academy. Primary endpoint: Serum favipiravir concentration. Started Sep 2021; status: enrolling by invitation.
02
Drugs
favipiravir
Beyond the preview
Go deeper on TCTR20210903002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210903002.